Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Arvid Carlsson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Anatomy
Activities & Behaviors
Physiology
Sign-in to see full Profile
Network (preview)
43
Carlsson, Maria
27
Waters, Nicholas
18
Nilsson, Lars
17
Fuxe, Kjell
15
Hacksell, Uli
14
Johansson, Anette
9
Winblad, Bengt
9
Sonesson, Christian
8
Smith, MW
7
Gottfries, Carl-Gerhard
7
Ekman, Agneta
6
Nissbrandt, Hans
6
Tedroff, Joakim
6
Elebring, Thomas
5
Waters, Susanna
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Arvid Carlsson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Starck G; Carlsson A; Ljungberg M; Forssell-Aronsson E
k-space analysis of point-resolved spectroscopy (PRESS) with regard to spurious echoes in in vivo (1)H MRS.
NMR in biomedicine 2009;22(2):137-47.
-
2008: Carlsson Arvid; Carlsson Maria L
Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications.
Brain research reviews 2008;58(2):374-8.
-
2008: Starck Göran; Ljungberg Maria; Nilsson Marie; Jönsson Lars; Lundberg Stefan; Ivarsson Tord; Ribbelin Susanne; Ekholm Sven; Carlsson Arvid; Forssell-Aronsson Eva; Carlsson Maria L
A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(7):1051-62.
-
2008: Rung Johan P; Rung Emilia; Helgeson Lisa; Johansson Anette M; Svensson Kjell; Carlsson Arvid; Carlsson Maria L
Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):899-908.
-
2008: Osterlund Anders; Carlsson Asa
[Primary health care doesn't follow SFAM's antibiotics prescription goals]
Läkartidningen 2008;105(4):210-4.
-
2007: Nilsson M; Hansson S; Carlsson A; Carlsson M L
Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice.
Neuroscience 2007;149(1):123-30.
-
2007: Lahti R A; Tamminga C A; Carlsson A
Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D(2) receptor function in vitro.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(9):1143-6.
-
2006: Carlsson A
The neurochemical circuitry of schizophrenia.
Pharmacopsychiatry 2006;39 Suppl 1():S10-4.
-
2006: Tretter F; Müller W E; Carlsson A
Identify the specific role of regional changes for the complex symptoms of schizophrenia.
Pharmacopsychiatry 2006;39 Suppl 1():S1-2.
-
2006: Carlsson Arvid; Carlsson Maria L
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
Dialogues in clinical neuroscience 2006;8(1):137-42.
-
2005: Rung Johan P; Carlsson Arvid; Rydén Markinhuhta Katarina; Carlsson Maria L
(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(5):827-32.
-
2005: Rung Johan P; Carlsson Arvid; Markinhuhta Katarina Rydén; Carlsson Maria L
The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(5):833-9.
-
2004: Lundberg Stefan; Carlsson Arvid; Norfeldt Per; Carlsson Maria L
Nicotine treatment of obsessive-compulsive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(7):1195-9.
-
2004: Nilsson Marie; Carlsson Arvid; Markinhuhta Katarina Rydén; Sonesson Clas; Pettersson Fredrik; Gullme Maria; Carlsson Maria L
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(4):677-85.
-
2004: Nydén Agneta; Carlsson Maria; Carlsson Arvid; Gillberg Christopher
Interhemispheric transfer in high-functioning children and adolescents with autism spectrum disorders: a controlled pilot study.
Developmental medicine and child neurology 2004;46(7):448-54.
-
2004: Carlsson M L; Carlsson A; Nilsson M
Schizophrenia: from dopamine to glutamate and back.
Current medicinal chemistry 2004;11(3):267-77.
-
2003: Grunder Gerhard; Carlsson Arvid; Wong Dean F
Mechanism of new antipsychotic medications: occupancy is not just antagonism.
Archives of general psychiatry 2003;60(10):974-7.
-
2003: Gefvert Ola; Lindström Leif H; Waters Nicholas; Waters Susanna; Carlsson Arvid; Tedroff Joakim
Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine.
Scandinavian journal of psychology 2003;44(3):289-92.
-
2002: Carlsson A
Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):777-87.
-
2002: Tamminga C A; Carlsson A
Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.
Current drug targets. CNS and neurological disorders 2002;1(2):141-7.
-
2001: Carlsson A
A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.
Bioscience reports 2001;21(6):691-710.
-
2001: Haadsma-Svensson S R; Cleek K A; Dinh D M; Duncan J N; Haber C L; Huff R M; Lajiness M E; Nichols N F; Smith M W; Svensson K A; Zaya M J; Carlsson A; Lin C H
Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans.
Journal of medicinal chemistry 2001;44(26):4716-32.
-
2001: Carlsson A
A paradigm shift in brain research.
Science (New York, N.Y.) 2001;294(5544):1021-4.
-
2001: Carlsson A
A half-century of neurotransmitter research: impact on neurology and psychiatry (Nobel lecture).
Chembiochem : a European journal of chemical biology 2001;2(7-8):484-93.
-
2001: Nilsson M; Waters S; Waters N; Carlsson A; Carlsson M L
A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(10):1181-96.
-
2001: Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson M L
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
Annual review of pharmacology and toxicology 2001;41():237-60.
-
2000: Kegeles L S; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann J J; Van Heertum R L; Cooper T B; Carlsson A; Laruelle M
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
Biological psychiatry 2000;48(7):627-40.
-
2000: Carlsson A; Waters N; Waters S; Carlsson M L
Network interactions in schizophrenia - therapeutic implications.
Brain research. Brain research reviews 2000;31(2-3):342-9.
-
1999: Carlsson A
Birth of neuropsychopharmacology--impact on brain research.
Brain research bulletin 1999;50(5-6):363.
-
1999: Carlsson A; Waters N; Carlsson M L
Neurotransmitter interactions in schizophrenia--therapeutic implications.
Biological psychiatry 1999;46(10):1388-95.
-
1999: Tedroff J; Ekesbo A; Sonesson C; Waters N; Carlsson A
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease.
Neurology 1999;53(7):1605-6.
-
1999: Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
Neuropharmacology 1999;38(3):331-8.
-
1999: Carlsson A; Waters N; Carlsson M L
Neurotransmitter interactions in schizophrenia-therapeutic implications.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():37-43.
-
1999: Carlsson M L; Martin P; Nilsson M; Sorensen S M; Carlsson A; Waters S; Waters N
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(2):123-9.
-
1999: Carlsson A; Hansson L O; Waters N; Carlsson M L
A glutamatergic deficiency model of schizophrenia.
The British journal of psychiatry. Supplement 1999;(37):2-6.
-
1998: Tedroff J; Torstenson R; Hartvig P; Sonesson C; Waters N; Carlsson A; Neu H; Fasth K J; Långström B
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity.
Synapse (New York, N.Y.) 1998;28(4):280-7.
-
1998: Lahti A C; Weiler M A; Corey P K; Lahti R A; Carlsson A; Tamminga C A
Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.
Biological psychiatry 1998;43(1):2-11.
-
1998: Lahti A C; Weiler M; Carlsson A; Tamminga C A
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(6-7):719-34.
-
1998: Martin P; Waters N; Schmidt C J; Carlsson A; Carlsson M L
Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(4-5):365-96.
-
1997: Martin P; Waters N; Waters S; Carlsson A; Carlsson M L
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
European journal of pharmacology 1997;335(2-3):107-16.
-
1997: Neu H; Hartvig P; Torstenson R; Fasth K J; Sonesson C; Waters N; Carlsson A; Tedroff J; Långström B
Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography.
Nuclear medicine and biology 1997;24(6):507-11.
-
1997: Nilsson M; Carlsson A; Carlsson M L
Glycine and D-serine decrease MK-801-induced hyperactivity in mice.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(11-12):1195-205.
-
1997: Carlsson A; Wong D T
Correction: a note on the discovery of selective serotonin reuptake inhibitors.
Life sciences 1997;61(12):1203.
-
1997: Martin P; Waters N; Carlsson A; Carlsson M L
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication).
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(4-5):561-4.
-
1997: Carlsson A; Hansson L O; Waters N; Carlsson M L
Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.
Life sciences 1997;61(2):75-94.
-
1996: Köpf I; Hultborn R; Weiss L; Carlsson A
Vascular cross-sectional area in rat mammary tumours; influence of noradrenaline.
Anticancer research 1996;16(3A):1161-4.
-
1995: Carlsson A
Neurocircuitries and neurotransmitter interactions in schizophrenia.
International clinical psychopharmacology 1995;10 Suppl 3():21-8.
-
1995: Stjernlöf P; Ennis M D; Hansson L O; Hoffman R L; Ghazal N B; Sundell S; Smith M W; Svensson K; Carlsson A; Wikström H
Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.
Journal of medicinal chemistry 1995;38(12):2202-16.
-
1995: Kujacic M; Carlsson A
In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine.
European journal of pharmacology 1995;278(1):9-15.
-
1995: Sonesson C; Barf T; Nilsson J; Dijkstra D; Carlsson A; Svensson K; Smith M W; Martin I J; Duncan J N; King L J
Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity.
Journal of medicinal chemistry 1995;38(8):1319-29.
-
1995: Kujacic M; Hansson L O; Carlsson A
Acute dopaminergic influence on plasma adrenaline levels in the rat.
European journal of pharmacology 1995;273(3):247-57.
-
1995: Svensson A; Carlsson M L; Carlsson A
Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.
Journal of neural transmission. General section 1995;101(1-3):127-48.
-
1995: Haadsma-Svensson S R; Smith M W; Svensson K; Waters N; Carlsson A
The chemical structure of U99194A.
Journal of neural transmission. General section 1995;99(1-3):I.
-
1994: Svensson A; Carlsson M L; Carlsson A
Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(7):1203-18.
-
1994: Svensson K; Carlsson A; Huff R M; Kling-Petersen T; Waters N
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
European journal of pharmacology 1994;263(3):235-43.
-
1994: Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
Journal of medicinal chemistry 1994;37(20):3263-73.
-
1994: Kujacic M; Carlsson A
Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(3):245-51.
-
1994: Sonesson C; Lin C H; Hansson L; Waters N; Svensson K; Carlsson A; Smith M W; Wikström H
Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.
Journal of medicinal chemistry 1994;37(17):2735-53.
-
1994: Kujacic M; Carlsson A
Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands.
Neuropharmacology 1994;33(8):983-7.
-
1994: Waters N; Hansson L; Löfberg L; Carlsson A
Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo.
European journal of pharmacology 1994;251(2-3):181-90.
-
1994: Kujacic M; Carlsson A
I. c. v. dopamine fails to alter adrenomedullary function in rats.
Journal of neural transmission. General section 1994;95(3):235-40.
-
1994: Carlsson M L; Engberg G; Carlsson A
Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
Journal of neural transmission. General section 1994;95(3):223-33.
-
1994: Martin P; Svensson A; Carlsson A; Carlsson M L
On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801.
Journal of neural transmission. General section 1994;95(2):113-21.
-
1994: Svensson K; Carlsson A; Waters N
Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release.
Journal of neural transmission. General section 1994;95(1):71-4.
-
1994: Hansson L O; Waters N; Winblad B; Gottfries C G; Carlsson A
Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue.
Journal of neural transmission. General section 1994;98(3):217-35.
-
1994: Waters N; Löfberg L; Haadsma-Svensson S; Svensson K; Sonesson C; Carlsson A
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour.
Journal of neural transmission. General section 1994;98(1):39-55.
-
1993: Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero A G; Martin I J; Duncan J N; King L J; Wikström H
Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
Journal of medicinal chemistry 1993;36(22):3409-16.
-
1993: Sonesson C; Waters N; Svensson K; Carlsson A; Smith M W; Piercey M F; Meier E; Wikström H
Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists.
Journal of medicinal chemistry 1993;36(21):3188-96.
-
1993: Svensson K; Eriksson E; Carlsson A
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects.
Neuropharmacology 1993;32(10):1037-45.
-
1993: Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
European journal of pharmacology 1993;242(2):151-63.
-
1993: Lin C H; Haadsma-Svensson S R; Phillips G; McCall R B; Piercey M F; Smith M W; Svensson K; Carlsson A; Chidester C G; Von Voigtlander P F
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
Journal of medicinal chemistry 1993;36(15):2208-18.
-
1993: Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
(S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Journal of medicinal chemistry 1993;36(15):2059-65.
-
1993: Waters N; Svensson K; Haadsma-Svensson S R; Smith M W; Carlsson A
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity.
Journal of neural transmission. General section 1993;94(1):11-9.
-
1993: Kujacic M; Carlsson A
Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.
Journal of neural transmission. General section 1993;92(2-3):73-9.
-
1993: Carlsson A
Thirty years of dopamine research.
Advances in neurology 1993;60():1-10.
-
1993: Carlsson A
On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity.
Journal of neural transmission. Supplementum 1993;40():1-12.
-
1992: Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall P A; Svensson K; Ekman A; Carlsson A
6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
Journal of medicinal chemistry 1992;35(22):3984-90.
-
1992: Carlsson A; Jonsson Y; Svensson K; Stahl B; Twetman S
Pit and fissure sealing and mutans streptococci levels in saliva.
American journal of dentistry 1992;5(5):280-2.
-
1992: Piercey M F; Lum J T; Hoffmann W E; Carlsson A; Ljung E; Svensson K
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
Brain research 1992;588(2):217-22.
-
1992: Carlsson A
Fifteen years of continued research in psychopharmacology.
Pharmacopsychiatry 1992;25(1):22-4.
-
1992: Carlsson A
Interaction between dopaminergic and serotonergic systems.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():616A-617A.
-
1992: Svensson A; Carlsson A; Carlsson M L
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
Journal of neural transmission. General section 1992;90(3):199-217.
-
1992: Svensson A; Carlsson M L; Carlsson A
Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control.
Journal of neural transmission. General section 1992;88(3):235-40.
-
1992: Tamminga C A; Cascella N G; Lahti R A; Lindberg M; Carlsson A
Pharmacologic properties of (-)-3PPP (preclamol) in man.
Journal of neural transmission. General section 1992;88(3):165-75.
-
1992: Carlsson A
Future directions in antipsychotic drug research.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():271A-272A.
-
1991: Kullingsjö H; Carlsson A; Svensson K
Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.
European journal of pharmacology 1991;205(3):241-6.
-
1991: Svensson K; Ekman A; Piercey M F; Hoffmann W E; Lum J T; Carlsson A
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(3):263-74.
-
1991: Carlsson M; Svensson A; Carlsson A
Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(6):568-73.
-
1991: Carlsson A; Fornstedt B
Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease.
Neurology 1991;41(5 Suppl 2):50-1; discussion 52.
-
1991: Fornstedt B; Carlsson A
Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
Neuropharmacology 1991;30(5):463-8.
-
1991: Wallin A; Carlsson A; Ekman R; Gottfries C G; Karlsson I; Svennerholm L; Widerlöv E
Hypothalamic monoamines and neuropeptides in dementia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1991;1(2):165-8.
-
1991: Fornstedt B; Carlsson A
Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
Journal of neurochemistry 1991;56(2):407-14.
-
1991: Svensson A; Carlsson M; Carlsson A
Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
Journal of neural transmission. General section 1991;85(1):69-77.
-
1991: Carlsson A; Fornstedt B
Possible mechanisms underlying the special vulnerability of dopaminergic neurons.
Acta neurologica Scandinavica. Supplementum 1991;136():16-8.
-
1991: Kujacic M; Svensson K; Löfberg L; Carlsson A
Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
Journal of neural transmission. General section 1991;84(3):195-209.
-
1990: Carlsson A
[Monoamine research--a productive field of particular importance in neuroscience]
Läkartidningen 1990;87(45):3764, 3767-9.
-
1990: Johansson A M; Fredriksson K; Hacksell U; Grol C J; Svensson K; Carlsson A; Sundell S
Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
Journal of medicinal chemistry 1990;33(10):2925-9.
-
1990: Waters N; Löfberg L; Svensson K; Carlsson A
Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent.
European journal of pharmacology 1990;187(3):425-34.
-
1990: Fornstedt B; Pileblad E; Carlsson A
In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Journal of neurochemistry 1990;55(2):655-9.
-
1990: Carlsson M; Carlsson A
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.
Trends in neurosciences 1990;13(7):272-6.
-
1990: Carlsson A
Schizophrenia: a neurotransmitter imbalance syndrome?
Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology 1990;10(1):35-42.
-
1990: Liljefors T; Bøgesø K P; Hyttel J; Wikström H; Svensson K; Carlsson A
Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.
Journal of medicinal chemistry 1990;33(3):1015-22.
-
1990: Fornstedt B; Bergh I; Rosengren E; Carlsson A
An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Journal of neurochemistry 1990;54(2):578-86.
-
1990: Kujacic M; Svensson K; Löfberg L; Carlsson A
Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists.
European journal of pharmacology 1990;177(3):163-70.
-
1990: Allard P; Alafuzoff I; Carlsson A; Eriksson K; Ericson E; Gottfries C G; Marcusson J O
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
European neurology 1990;30(4):181-5.
-
1990: Carlsson M; Carlsson A
Schizophrenia: a subcortical neurotransmitter imbalance syndrome?
Schizophrenia bulletin 1990;16(3):425-32.
-
1989: Wikström H; Andersson B; Svensson A; Humber L G; Asselin A A; Svensson K; Ekman A; Carlsson A; Nilsson I; Chidester C
Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.
Journal of medicinal chemistry 1989;32(10):2273-6.
-
1989: Waters N; Pettersson G; Carlsson A; Svensson K
The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(2):161-9.
-
1989: Wallin A; Alafuzoff I; Carlsson A; Eckernäs S A; Gottfries C G; Karlsson I; Svennerholm L; Winblad B
Neurotransmitter deficits in a non-multi-infarct category of vascular dementia.
Acta neurologica Scandinavica 1989;79(5):397-406.
-
1989: Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Journal of neurochemistry 1989;52(4):1170-82.
-
1989: Fornstedt B; Brun A; Rosengren E; Carlsson A
The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.
Journal of neural transmission. Parkinson's disease and dementia section 1989;1(4):279-95.
-
1989: Carlsson M; Carlsson A
Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
Journal of neural transmission. Parkinson's disease and dementia section 1989;1(4):317-22.
-
1989: Carlsson M; Carlsson A
Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
Journal of neural transmission 1989;77(1):65-71.
-
1989: Carlsson M; Carlsson A
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
Journal of neural transmission 1989;75(3):221-6.
-
1989: Fornstedt B; Carlsson A
A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
Journal of neural transmission 1989;76(2):155-61.
-
1989: Carlsson M; Carlsson A
Effects of mild stress on adrenal and heart catecholamines in male and female rats.
Journal of neural transmission 1989;77(2-3):217-26.
-
1988: Carlsson M; Carlsson A
In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(4):345-9.
-
1988: Carlsson A
The current status of the dopamine hypothesis of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1988;1(3):179-86.
-
1988: Snape B M; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
The Journal of pharmacy and pharmacology 1988;40(9):620-6.
-
1988: Hjorth S; Clark D; Carlsson A
Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation.
European journal of pharmacology 1988;152(3):207-15.
-
1988: Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A
NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(2):148-61.
-
1988: Eriksson T; Granérus A K; Linde A; Carlsson A
'On-off' phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma.
Neurology 1988;38(8):1245-8.
-
1988: Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
Journal of medicinal chemistry 1988;31(6):1080-4.
-
1988: Carlsson A
Peptide neurotransmitters--redundant vestiges?
Pharmacology & toxicology 1988;62(5):241-2.
-
1988: Pileblad E; Carlsson A
Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Pharmacology & toxicology 1988;62(4):213-22.
-
1988: Arvidsson L E; Johansson A M; Hacksell U; Nilsson J L; Svensson K; Hjorth S; Magnusson T; Carlsson A; Lindberg P; Andersson B
N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists.
Journal of medicinal chemistry 1988;31(1):92-9.
-
1988: Carlsson A
Speculations on the control of mental and motor functions by dopamine-modulated cortico-striato-thalamo-cortical feedback loops.
The Mount Sinai journal of medicine, New York 1988;55(1):6-10.
-
1988: Hajós M; Engberg G; Nissbrandt H; Magnusson T; Carlsson A
Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum.
Journal of neural transmission 1988;74(3):129-39.
-
1988: Hajos M; Hjorth S; Svensson K; Carlsson A
In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1988;70(3):577-84.
-
1988: Carlsson A
Reflections on the history of psychopharmacology.
Psychopharmacology series 1988;5():3-11.
-
1988: Hjorth S; Carlsson A
In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
Journal of neural transmission 1988;72(2):83-97.
-
1988: Eriksson T; Carlsson A
Beta-adrenergic control of brain uptake of large neutral amino acids.
Life sciences 1988;42(17):1583-9.
-
1988: Carlsson M; Carlsson A
A regional study of sex differences in rat brain serotonin.
Progress in neuro-psychopharmacology & biological psychiatry 1988;12(1):53-61.
-
1987: Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
Journal of medicinal chemistry 1987;30(12):2169-74.
-
1987: Ahlenius S; Carlsson A; Hillegaart V; Hjorth S; Larsson K
Region-selective activation of brain monoamine synthesis by sexual activity in the male rat.
European journal of pharmacology 1987;144(1):77-82.
-
1987: Arvidsson L E; Johansson A M; Hacksell U; Nilsson J L; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Journal of medicinal chemistry 1987;30(11):2105-9.
-
1987: Carlsson M; Carlsson A; Eriksson E
The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
European journal of pharmacology 1987;142(1):39-43.
-
1987: Johansson A M; Nilsson J L; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
Journal of medicinal chemistry 1987;30(10):1827-37.
-
1987: Wikström H; Andersson B; Elebring T; Jacyno J; Allinger N L; Svensson K; Carlsson A; Sundell S
Resolved cis-10-hydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b- octahydrobenzo[f]quinoline : central serotonin stimulating properties.
Journal of medicinal chemistry 1987;30(9):1567-73.
-
1987: Nissbrandt H; Carlsson A
Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Journal of neurochemistry 1987;49(3):959-67.
-
1987: Sharp T; Zetterström T; Series H G; Carlsson A; Grahame-Smith D G; Ungerstedt U
HPLC-EC analysis of catechols and indoles in rat brain dialysates.
Life sciences 1987;41(7):869-72.
-
1987: Johansson A M; Nilsson J L; Karlén A; Hacksell U; Svensson K; Carlsson A; Kenne L; Sundell S
C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
Journal of medicinal chemistry 1987;30(7):1135-44.
-
1987: Johansson A M; Arvidsson L E; Hacksell U; Nilsson J L; Svensson K; Carlsson A
Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
Journal of medicinal chemistry 1987;30(4):602-11.
-
1987: Hajós M; Hjorth S; Carlsson A
Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat.
Neuroscience letters 1987;75(2):199-204.
-
1987: Svensson K; Alföldi P; Hajós M; Rubicsek G; Johansson A M; Carlsson A; Obál F
Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat.
Pharmacology, biochemistry, and behavior 1987;26(1):123-9.
-
1987: Pileblad E; Carlsson A
The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brain.
Neuropharmacology 1987;26(1):101-5.
-
1987: Carlsson A
Development of new pharmacological approaches in Parkinson's disease.
Advances in neurology 1987;45():513-8.
-
1987: Hjorth S; Carlsson A; Engel J A
Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm.
Psychopharmacology 1987;92(3):371-5.
-
1987: Carlsson A
Perspectives on the discovery of central monoaminergic neurotransmission.
Annual review of neuroscience 1987;10():19-40.
-
1987: Hjorth S; Carlsson A
Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.
Psychopharmacology 1987;93(4):534-7.
-
1987: Carlsson A
Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups.
Gerontology 1987;33(3-4):159-67.
-
1986: Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson A M; Eriksson E
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
European journal of pharmacology 1986;130(3):237-42.
-
1986: Svensson K; Johansson A M; Magnusson T; Carlsson A
(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
Naunyn-Schmiedeberg's archives of pharmacology 1986;334(3):234-45.
-
1986: Carlsson A; Sharp T; Zetterström T; Ungerstedt U
Determination of dopamine and its metabolites in small volumes of rat brain dialysates using small-bore liquid chromatography with electrochemical detection.
Journal of chromatography 1986;368(2):299-308.
-
1986: Rollema H; Mastebroek D; Wikström H; Svensson K; Carlsson A; Sundell S
Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics.
Journal of medicinal chemistry 1986;29(10):1889-95.
-
1986: Hjorth S; Carlsson A
Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
European journal of pharmacology 1986;129(1-2):131-8.
-
1986: Carlsson M; Eriksson E; Nilsson C; Carlsson A
Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion.
Neuropharmacology 1986;25(8):951-4.
-
1986: Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
Naunyn-Schmiedeberg's archives of pharmacology 1986;333(3):205-18.
-
1986: Fornstedt B; Rosengren E; Carlsson A
Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
Neuropharmacology 1986;25(4):451-4.
-
1986: Hjorth S; Engel J A; Carlsson A
Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat.
Pharmacology, biochemistry, and behavior 1986;24(2):237-40.
-
1986: Svensson K; Carlsson A; Johansson A M; Arvidsson L E; Nilsson J L
A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
Journal of neural transmission 1986;65(1):29-38.
-
1986: Gottfries C G; Bartfai T; Carlsson A; Eckernäs S; Svennerholm L
Multiple biochemical deficits in both gray and white matter of Alzheimer brains.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):405-13.
-
1986: Hacksell U; Arvidsson L E; Johansson A M; Nilsson J L; Sanchez D; Lindberg P; Wikström H; Svensson K; Hjorth S; Carlsson A
Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives.
Acta pharmaceutica Suecica 1986;23(2):77-90.
-
1986: Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson A M; Arvidsson L E; Hacksell U
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
Journal of neural transmission 1986;65(1):1-27.
-
1986: Hajós M; Svensson K; Nissbrandt H; Obál F; Carlsson A
Effects of capsaicin on central monoaminergic mechanisms in the rat.
Journal of neural transmission 1986;66(3-4):221-42.
-
1986: Pileblad E; Carlsson A
In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain.
Journal of neural transmission 1986;66(3-4):171-87.
-
1986: Eriksson T; Wiesel K; Carlsson A
Rat brain concentration of administered amino acids: dependence on time of day for administration.
Journal of neural transmission 1986;65(1):83-91.
-
1985: Nissbrandt H; Pileblad E; Carlsson A
Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
The Journal of pharmacy and pharmacology 1985;37(12):884-9.
-
1985: Hjorth S; Carlsson A
(-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis.
Neuropharmacology 1985;24(11):1143-6.
-
1985: Röjdmark S; Carlsson A
Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
Acta endocrinologica 1985;110(2):221-6.
-
1985: Pileblad E; Fornstedt B; Clark D; Carlsson A
Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
The Journal of pharmacy and pharmacology 1985;37(10):707-11.
-
1985: Johansson A M; Arvidsson L E; Hacksell U; Nilsson J L; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Journal of medicinal chemistry 1985;28(8):1049-53.
-
1985: Hjorth S; Clark D; Carlsson A
Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.
Life sciences 1985;37(7):673-84.
-
1985: Pileblad E; Carlsson A
Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain.
Neuropharmacology 1985;24(7):689-92.
-
1985: Clark D; Engberg G; Pileblad E; Svensson T H; Carlsson A; Freeman A S; Bunney B S
An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(4):344-54.
-
1985: Carlsson A
Neurotransmitter changes in the aging brain.
Danish medical bulletin 1985;32 Suppl 1():40-3.
-
1985: Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson L E; Johansson A M; Nilsson J L; Svensson K; Hjorth S; Carlsson A
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
Journal of medicinal chemistry 1985;28(2):215-25.
-
1985: Hjorth S; Carlsson A; Clark D; Svensson K; Sanchez D
Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP.
European journal of pharmacology 1985;107(3):299-304.
-
1985: Carlsson A; Löfberg L
In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum.
Journal of neural transmission 1985;64(3-4):173-85.
-
1985: Hjorth S; Clark D; Svensson K; Carlsson A; Thorberg O
Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.
Journal of neural transmission 1985;64(3-4):187-98.
-
1985: Clark D; Hjorth S; Carlsson A
Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
Journal of neural transmission 1985;62(1-2):1-52.
-
1985: Carlsson A
Pharmacological properties of presynaptic dopamine receptor agonists.
Psychopharmacology. Supplementum 1985;2():31-8.
-
1985: Rosengren E; Linder-Eliasson E; Carlsson A
Detection of 5-S-cysteinyldopamine in human brain.
Journal of neural transmission 1985;63(3-4):247-53.
-
1985: Clark D; Hjorth S; Carlsson A
Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.
Journal of neural transmission 1985;62(3-4):171-207.
-
1985: Carlsson M; Svensson K; Eriksson E; Carlsson A
Rat brain serotonin: biochemical and functional evidence for a sex difference.
Journal of neural transmission 1985;63(3-4):297-313.
-
1984: Engel J A; Hjorth S; Svensson K; Carlsson A; Liljequist S
Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
European journal of pharmacology 1984;105(3-4):365-8.
-
1984: Clark D; Hjorth S; Carlsson A
(+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
European journal of pharmacology 1984;106(1):185-9.
-
1984: Hacksell U; Johansson A M; Arvidsson L; Nilsson J L; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
Journal of medicinal chemistry 1984;27(8):1003-7.
-
1984: Arvidsson L E; Hacksell U; Johansson A M; Nilsson J L; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
Journal of medicinal chemistry 1984;27(1):45-51.
-
1984: Eriksson T; Magnusson T; Carlsson A; Linde A; Granérus A K
"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.
Journal of neural transmission 1984;59(3):229-40.
-
1984: Carlsson A
Current theories on the mode of action of antidepressant drugs.
Advances in biochemical psychopharmacology 1984;39():213-21.
-
1984: Larsson M; Ohman R; Wallin L; Wålinder J; Carlsson A
Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools.
Journal of neural transmission 1984;60(2):115-32.
-
1984: Eriksson T; Carlsson A; Hagman M; Jagenburg R
Beta-adrenergic influence on brain concentrations of monoamine precursors.
Advances in biochemical psychopharmacology 1984;39():263-70.
-
1984: Pileblad E; Nissbrandt H; Carlsson A
Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
Journal of neural transmission 1984;60(3-4):199-203.
-
1983: Eriksson E; Modigh K; Carlsson A; Wikström H
Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.
European journal of pharmacology 1983;96(1-2):29-36.
-
1983: Eriksson T; Magnusson T; Carlsson A; Hagman M; Jagenburg R
Decrease in plasma amino acids in man after an acute dose of ethanol.
Journal of studies on alcohol 1983;44(2):215-21.
-
1983: Benedetti M S; Boucher T; Carlsson A; Fowler C J
Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
Biochemical pharmacology 1983;32(1):47-52.
-
1983: Häggström J E; Gunne L M; Carlsson A; Wikström H
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.
Journal of neural transmission 1983;58(3-4):135-42.
-
1983: Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson L E; Johansson A; Nilsson J L
The search for selective dopaminergic autoreceptor agonists.
Journal of neural transmission. Supplementum 1983;18():131-7.
-
1983: Carlsson A
Dopamine receptor agonists: intrinsic activity vs. state of receptor.
Journal of neural transmission 1983;57(4):309-15.
-
1983: Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson L E; Johansson A
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
Psychopharmacology 1983;81(2):89-99.
-
1983: Carlsson A
Are "on-off" effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway?
Journal of neural transmission. Supplementum 1983;19():153-61.
-
1983: Gottfries C G; Adolfsson R; Aquilonius S M; Carlsson A; Eckernäs S A; Nordberg A; Oreland L; Svennerholm L; Wiberg A; Winblad B
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
Neurobiology of aging 1983;4(4):261-71.
-
1983: García-Sevilla J A; Magnusson T; Carlsson A; Folkers K
Substance P: structural requirements for the activation of brain catecholamine synthesis and locomotor activity in rats.
Arzneimittel-Forschung 1983;33(9):1249-54.
-
1983: Clark D; Carlsson A; Hjorth S; Engel J; Lindberg P
The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat.
Psychopharmacology 1983;81(1):14-7.
-
1982: Hjorth S; Jackson D; Carlsson A; Lindberg P
A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP.
Psychopharmacology bulletin 1982;18(4):149-52.
-
1982: Hjorth S; Carlsson A
Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings.
European journal of pharmacology 1982;83(3-4):299-303.
-
1982: Clark D; Carlsson A; Hjorth S; Svensson K; Engel J; Sanchez D
Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies.
European journal of pharmacology 1982;83(1-2):131-4.
-
1982: Wikström H; Sanchez D; Lindberg P; Arvidsson L E; Hacksell U; Johansson A; Nilsson J L; Hjorth S; Carlsson A
Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
Journal of medicinal chemistry 1982;25(8):925-31.
-
1982: Carlsson A
Recent observations on new potential and established antidepressant drugs.
Pharmacopsychiatria 1982;15(4):116-20.
-
1982: Nyberg P; Almay B G; Carlsson A; Masters C; Winblad B
Brain monoamine abnormalities in the two types of Creutzfeldt-Jakob disease.
Acta neurologica Scandinavica 1982;66(1):16-24.
-
1982: Sakabe T; Dahlgren N; Carlsson A; Siesjö B K
Effect of diazepam on cerebral monoamine synthesis during hypoxia and hypercapnia in the rat.
Acta physiologica Scandinavica 1982;115(1):57-65.
-
1982: Eriksson T; Carlsson A
Adrenergic influence on rat plasma concentrations of tyrosine and tryptophan.
Life sciences 1982;30(17):1465-72.
-
1982: Carlsson A
Exposure to toluene: uptake, distribution and elimination in man.
Scandinavian journal of work, environment & health 1982;8(1):43-55.
-
1982: Eriksson T; Carlsson A
Isoprenaline increases brain concentrations of administered L-dopa and L-tryptophan in the rat.
Psychopharmacology 1982;77(1):98-100.
-
1982: Jackson D; Carlsson A; Hjorth S; Lindberg P
A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
Journal of neural transmission 1982;53(4):233-45.
-
1982: Nyberg P; Winblad B; Carlsson A
Monoamine concentrations in the human brain. A comparison between two methods of tissue handling.
Journal of neural transmission 1982;54(1-2):85-90.
-
1981: Hacksell U; Arvidsson L E; Svensson U; Nilsson J L; Sanchez D; Wikström H; Lindberg P; Hjorth S; Carlsson A
3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.
Journal of medicinal chemistry 1981;24(12):1475-82.
-
1981: Eriksson T; Magnusson T; Carlsson A; Hagman M; Jagenburg R; Edén S
Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acids.
Naunyn-Schmiedeberg's archives of pharmacology 1981;317(3):214-8.
-
1981: Ahlenius S; Larsson K; Svensson L; Hjorth S; Carlsson A; Lindberg P; Wikström H; Sanchez D; Arvidsson L E; Hacksell U; Nilsson J L
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior.
Pharmacology, biochemistry, and behavior 1981;15(5):785-92.
-
1981: Eriksson T; Carlsson A; Hagman M; Jagenburg R
Effects of pentobarbital and diazepam on rat plasma amino acid patterns.
Naunyn-Schmiedeberg's archives of pharmacology 1981;317(2):165-7.
-
1981: Arvidsson L E; Hacksell U; Nilsson J L; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
Journal of medicinal chemistry 1981;24(8):921-3.
-
1981: Hacksell U; Arvidsson L E; Svensson U; Nilsson J L; Wikström H; Lindberg P; Sanchez D; Hjorth S; Carlsson A; Paalzow L
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity.
Journal of medicinal chemistry 1981;24(4):429-34.
-
1981: Hjorth S; Carlsson A; Wikström H; Lindberg P; Sanchez D; Hacksell U; Arvidsson L E; Svensson U; Nilsson J L
3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.
Life sciences 1981;28(11):1225-38.
-
1981: Carlsson A; Fowler C J; Magnusson T; Oreland L; Wiberg A
The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection.
Naunyn-Schmiedeberg's archives of pharmacology 1981;316(1):51-5.
-
1981: Fowler C J; Carlsson A; Winblad B
Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics.
Journal of neural transmission 1981;52(1-2):23-32.
-
1981: Carlsson A
Some current problems related to the mode of action of antidepressant drugs.
Acta psychiatrica Scandinavica. Supplementum 1981;290():63-6.
-
1980: Eriksson T; Carlsson A
Ethanol-induced increase in brain concentrations of administered neutral amino acids.
Naunyn-Schmiedeberg's archives of pharmacology 1980;314(1):47-50.
-
1980: Hjorth S; Carlsson A; Lindberg P
A new centrally acting DA-receptor agonist with selectivity for autoreceptors.
Psychopharmacology bulletin 1980;16(3):85-90.
-
1980: Eriksson T; Carlsson A; Liljequist S; Hagman M; Jagenburg R
Decrease in plasma amino acids in rat after acute administration of ethanol.
The Journal of pharmacy and pharmacology 1980;32(7):512-3.
-
1980: Oreland L; Fowler C J; Carlsson A; Magnusson T
Monoamine oxidase -A and -B activity in the rat brain after hemitransection.
Life sciences 1980;26(2):139-46.
-
1980: García-Sevilla J A; Magnusson T; Carlsson A
Effects of enkephalins and two enzyme resistant analogues on monoamine synthesis and metabolism in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1980;310(3):211-8.
-
1980: Carlsson A; Svennerholm L; Winblad B
Seasonal and circadian monoamine variations in human brains examined post mortem.
Acta psychiatrica Scandinavica. Supplementum 1980;280():75-85.
-
1980: Carlsson A; Adolfsson R; Aquilonius S M; Gottfries C G; Oreland L; Svennerholm L; Winblad B
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
Advances in biochemical psychopharmacology 1980;23():295-304.
-
1980: Muller P; Svensson T H; Carlsson A
Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists.
Advances in biochemical psychopharmacology 1980;24():69-74.
-
1979: Hacksell U; Svensson U; Nilsson J L; Hjorth S; Carlsson A; Wikström H; Lindenberg P; Sanchez D
N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.
Journal of medicinal chemistry 1979;22(12):1469-75.
-
1979: Agardh C D; Carlsson A; Linqvist M; Siesjö B K
The effect of pronounced hypoglycemia on monoamine metabolism in rat brain.
Diabetes 1979;28(9):804-9.
-
1979: Eriksson T; Liljequist S; Carlsson A
Ethanol-induced increase in the penetration of exogenously administered L-dopa through the blood-brain barrier.
The Journal of pharmacy and pharmacology 1979;31(9):636-7.
-
1979: Ahtee L; Carlsson A
Dual action of methadone on 5-HT synthesis and metabolism.
Naunyn-Schmiedeberg's archives of pharmacology 1979;307(1):51-6.
-
1979: Engel J; Ahlenius S; Almgren O; Carlsson A; Larsson K; Södersten P
Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats.
Pharmacology, biochemistry, and behavior 1979;10(1):149-54.
-
1979: Fowler C J; Oreland L; Wiberg A; Carlsson A; Magnusson T
The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form.
Medical biology 1979;57(6):406-11.
-
1979: Garcia-Sevilla J A; Magnusson T; Carlsson A
Opposite effects of naloxone on substance P-induced changes in brain DOPA synthesis and in locomotor activity in rats.
Journal of neural transmission 1979;45(3):185-93.
-
1978: García-Sevilla J A; Magnusson T; Carlsson A; Leban J; Folkers K
Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover.
Naunyn-Schmiedeberg's archives of pharmacology 1978;305(3):213-8.
-
1978: Calderini G; Carlsson A; Nordström C H
Influence of transient ischemia on monoamine metabolism in the rat brain during nitrous oxide and phenobarbitone anaesthesia.
Brain research 1978;157(2):303-10.
-
1978: Calderini G; Carlsson A; Nordström C H
Monoamine metabolism during bicuculline-induced epileptic seizures in the rat.
Brain research 1978;157(2):295-302.
-
1978: Liljequist S; Carlsson A
Alteration of central catecholamine metabolism following acute administration of ethanol.
The Journal of pharmacy and pharmacology 1978;30(11):728-30.
-
1978: Garcia-Sevilla J A; Magnusson T; Carlsson A
Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover.
Brain research 1978;155(1):159-64.
-
1978: Garcia-Sevilla J A; Ahtee L; Magnusson T; Carlsson A
Opiate-receptor mediated changes in monoamine synthesis in rat brain.
The Journal of pharmacy and pharmacology 1978;30(10):613-21.
-
1978: Wikström H; Lindberg P; Martinson P; Hjorth S; Carlsson A
Pivaloyl esters of N,N-dialkylated dopamine congeners. Central dopamine-receptor stimulating activity.
Journal of medicinal chemistry 1978;21(9):864-7.
-
1978: Garcia de Yebenes Prous J; Carlsson A; Mena Gomez M A
The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1978;304(2):95-9.
-
1978: Biswas B; Carlsson A
Effect of intraperitoneally administered GABA on the locomotor activity of mice.
Psychopharmacology 1978;59(1):91-4.
-
1978: Carlsson A; Lindqvist M
Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1978;303(2):157-64.
-
1978: Biswas B; Carlsson A
Potentiation by neuroleptic agents of the inhibitory action of intraperitoneally administered GABA on the locomotor activity of mice.
Pharmacology, biochemistry, and behavior 1978;8(6):651-4.
-
1978: Biswas B; Carlsson A
On the mode of action of diazepam on brain catecholamine metabolism.
Naunyn-Schmiedeberg's archives of pharmacology 1978;303(1):73-8.
-
1978: Carlsson A; Henning M; Lindberg P; Martinson P; Trolin G; Waldeck B; Wickberg B
On the disulfiram-like effect of coprine, the pharmacologically active principle of Coprinus atramentarius.
Acta pharmacologica et toxicologica 1978;42(4):292-7.
-
1978: Carlsson A
Does dopamine have a role in schizophrenia?
Biological psychiatry 1978;13(1):3-21.
-
1978: Carlsson A
Antipsychotic drugs, neurotransmitters, and schizophrenia.
The American journal of psychiatry 1978;135(2):165-73.
-
1978: Carlsson A
Age-dependent changes in central dopaminergic and other monoaminergic systems.
Advances in experimental medicine and biology 1978;113():1-13.
-
1978: Carlsson A; Lindqvist M
Effects of antidepressant agents on the synthesis of brain monoamines.
Journal of neural transmission 1978;43(2):73-91.
-
1978: Mena Gomez M A; Carlsson A; Garcia de Yebenes J
The effect of beta-alanine on motor behaviour, body temperature and cerebral monoamine metabolism in rat.
Journal of neural transmission 1978;43(1):1-9.
-
1977: Garcia de Yebenes Prous J; Carlsson A; Mena Gomez M A
The effect of CO2 on monoamine metabolism in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1977;301(1):11-5.
-
1977: Carlsson A
Does dopamine play a role in schizophrenia?
Psychological medicine 1977;7(4):583-97.
-
1977: Ablad B; Almgren O; Carlsson A; Henning M; Jonasson J; Ljung B
Reduced adrenal amine synthesis in spontaneously hypertensive rats after long-term treatment with propranolol.
British journal of pharmacology 1977;61(2):318-20.
-
1977: Ohman R; Larsson M; Nilsson I M; Engel J; Carlsson A
Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.
Naunyn-Schmiedeberg's archives of pharmacology 1977;299(2):105-14.
-
1977: Biswas B; Carlsson A
The effect of intraperitoneally administered GABA on brain monoamine metabolism.
Naunyn-Schmiedeberg's archives of pharmacology 1977;299(1):47-51.
-
1977: Biswas B; Carlsson A
The effect of intracerebroventricularly administered GABA on brain monoamine metabolism.
Naunyn-Schmiedeberg's archives of pharmacology 1977;299(1):41-6.
-
1977: Carlsson A; Holmin T; Lindqvist M; Siesjö B K
Effect of hypercapnia and hypocapnia on tryptophan and tyrosine hydroxylation in rat brain.
Acta physiologica Scandinavica 1977;99(4):503-9.
-
1977: Strömbom U; Svensson T H; Carlsson A
Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
Psychopharmacology 1977;51(3):293-9.
-
1977: Kehr W; Carlsson A; Lindqvist M
Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(2):111-7.
-
1977: Carlsson A
Dopaminergic autoreceptors: background and implications.
Advances in biochemical psychopharmacology 1977;16():439-41.
-
1977: Carlsson A; Kehr W; Lindqvist M
Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
Journal of neural transmission 1977;40(2):99-113.
-
1977: Carlsson A; Biswas B; Lindqvist M
Influence of GABA and GABA-like drugs on monoaminergic mechanisms.
Advances in biochemical psychopharmacology 1977;16():471-5.
-
1977: Engel J; Carlsson A
Catecholamines and behavior.
Current developments in psychopharmacology 1977;4():1-32.
-
1976: Cott J; Carlsson A; Engel J; Lindqvist M
Suppression of ethanol-induced locomotor stimulation by GABA-like drugs.
Naunyn-Schmiedeberg's archives of pharmacology 1976;295(3):203-9.
-
1976: Almgren O; Snider S R; Carlsson A
Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment.
Naunyn-Schmiedeberg's archives of pharmacology 1976;292(2):133-6.
-
1976: Carlsson A
The contribution of drug research to investigating the nature of endogenous depression.
Pharmakopsychiatrie, Neuro-Psychopharmakologie 1976;9(1):2-10.
-
1976: Carlsson A; Kehr W; Lindqvist M
The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain.
Journal of neural transmission 1976;39(1-2):1-19.
-
1976: Carlsson A; Winblad B
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia.
Journal of neural transmission 1976;38(3-4):271-6.
-
1976: Kehr W; Lindqvist M; Carlsson A
Distribution of dopamine in the rat cerebral cortex.
Journal of neural transmission 1976;38(3-4):173-80.
-
1976: Carlsson A
Some aspects of dopamine in the basal ganglia.
Research publications - Association for Research in Nervous and Mental Disease 1976;55():181-9.
-
1976: Magnusson T; Carlsson A; Fisher G H; Chang D; Folkers K
Effect of synthetic substance P on monoaminergic mechanisms in brain.
Journal of neural transmission 1976;38(2):89-93.
-
1975: Brown R M; Kehr W; Carlsson A
Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia.
Brain research 1975;85(3):491-509.
-
1975: Ahlenius S; Carlsson A; Engel J
Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat.
Journal of neural transmission 1975;36(3-4):327-33.
-
1975: Kehr W; Carlsson A; Lindqvist M
Biochemical aspects of dopamine agonists.
Advances in neurology 1975;9():185-95.
-
1975: Lindqvist M; Kehr W; Carlsson A
Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.
Journal of neural transmission 1975;36(3-4):161-76.
-
1975: Carlsson A
Drugs acting through dopamine release.
Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):401-5.
-
1975: Carlsson A
Monoamine-depleting drugs.
Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):393-400.
-
1975: Carlsson A
Monoamine precursors and analogues.
Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):381-92.
-
1975: Waldeck B; Snider S R; Brown R; Carlsson A
Studies on the synthesis and subcellular distribution of dopamine in the rat adrenal medulla.
Naunyn-Schmiedeberg's archives of pharmacology 1975;287(1):1-10.
-
1974: Carlsson A; Kehr W; Lindguist M
Proceedings: Short-term control of tyrosine hydroxylase.
Psychopharmacology bulletin 1974;10(3):28.
-
1974: Carlsson A; Engel J; Strömbom U; Svensson T H; Waldeck B
Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
Naunyn-Schmiedeberg's archives of pharmacology 1974;283(2):117-28.
-
1974: Brown R M; Snider S R; Carlsson A
Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. II. The central nervous system.
Journal of neural transmission 1974;35(4):293-305.
-
1974: Snider S R; Brown R M; Carlsson A
Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. I. The adrenal medulla.
Journal of neural transmission 1974;35(4):283-91.
-
1974: Carlsson A; Lindqvist M; Kehr W
Postmortal accumulation of 3-methoxytyramine in brain.
Naunyn-Schmiedeberg's archives of pharmacology 1974;284(4):365-72.
-
1974: Lindqvist M; Kehr W; Carlsson A
Effect of pentobarbitone and diethyl ether on the synthesis of monoamines in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1974;284(3):263-77.
-
1974: Carlsson A
Antipsychotic drugs and catecholamine synapses.
Journal of psychiatric research 1974;11():57-64.
-
1974: Carlsson A
Some aspects of dopamine in the central nervous system.
Advances in neurology 1974;5():59-68.
-
1974: Carlsson A; Lindqvist M
Studies on the neurogenic short-term control of adrenomedullary hormone synthesis.
Journal of neural transmission 1974;35(3):181-96.
-
1974: Carlsson A; Kehr W; Lindqvist M
Short-term control of tyrosine hydroxylase.
Advances in biochemical psychopharmacology 1974;12(0):135-42.
-
1974: Carlsson A
Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
Advances in biochemical psychopharmacology 1974;10():75-81.
-
1973: Davis J N; Carlsson A; MacMillan V; Siesjö B K
Brain tryptophan hydroxylation: dependence on arterial oxygen tension.
Science (New York, N.Y.) 1973;182(107):72-4.
-
1973: Davis J N; Carlsson A
The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
Journal of neurochemistry 1973;21(4):783-90.
-
1973: Ahlenius S; Carlsson A; Engel J; Svensson T; Södersten P
Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man.
Clinical pharmacology and therapeutics 1973;14(4):586-91.
-
1973: Carlsson A
[Mode of action of tricyclic antidepressants]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1973;93(17):1300-2.
-
1973: Carlsson A
[Theories on the models of action of antipsychotic drugs]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1973;93(17):1298-300.
-
1973: Carlsson A; Lindqvist M
Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.
The Journal of pharmacy and pharmacology 1973;25(6):437-40.
-
1973: Brown R; David J N; Carlsson A
Dopa reversal of hypoxia-induced disruption of the conditioned avoidance response.
The Journal of pharmacy and pharmacology 1973;25(5):412-4.
-
1973: Snider S R; Almgren O; Carlsson A
The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1973;278(1):1-12.
-
1973: Davis J N; Carlsson A
Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanaesthetized rat brain.
Journal of neurochemistry 1973;20(3):913-5.
-
1973: Carlsson A; Magnusson T; Svensson T H; Waldeck B
Effect of ethanol on the metabolism of brain catecholamines.
Psychopharmacologia 1973;30(1):27-36.
-
1973: Carlsson A; Lindqvist M; Magnusson T; Atack C
Effect of acute transection on the synthesis and turnover of 5-HT in the rat spinal cord.
Naunyn-Schmiedeberg's archives of pharmacology 1973;227(1):1-12.
-
1973: Carlsson A; Lindqvist M
In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain.
Journal of neural transmission 1973;34(2):79-91.
-
1972: Snider S R; Carlsson A
The adrenal dopamine as an indicator of adrenomedullary hormone biosynthesis.
Naunyn-Schmiedeberg's archives of pharmacology 1972;275(4):347-57.
-
1972: Atack C; Carlsson A
In vitro release of endogenous histamine, together with noradrenaline and 5-hydroxytryptamine, from slices of mouse cerebral hemispheres.
The Journal of pharmacy and pharmacology 1972;24(12):990-2.
-
1972: Kehr W; Carlsson A; Lindqvist M; Magnusson T; Atack C
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.
The Journal of pharmacy and pharmacology 1972;24(9):744-7.
-
1972: Carlsson A; Bédard P; Lindqvist M; Magnusson T
The influence of nerve-impulse flow on the synthesis and metabolism of hydroxytryptamine.
The Biochemical journal 1972;128(3):70P-71P.
-
1972: Carlsson A; Kehr W; Lindqvist M; Magnusson T; Atack C V
Regulation of monoamine metabolism in the central nervous system.
Pharmacological reviews 1972;24(2):371-84.
-
1972: Carlsson A; Davis J N; Kehr W; Lindqvist M; Atack C V
Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.
Naunyn-Schmiedeberg's archives of pharmacology 1972;275(2):153-68.
-
1972: Carlsson A; Engel J; Svensson T H
Inhibition of ethanol-induced excitation in mice and rats by -methyl-p-tyrosine.
Psychopharmacologia 1972;26(3):307-12.
-
1972: Carlsson A; Bédard P; Lindqvist M; Magnusson T
The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system.
Biochemical Society symposium 1972;(36):17-32.
-
1972: Carlsson A
Biochemical and pharmacological aspects of Parkinsonism.
Acta neurologica Scandinavica. Supplementum 1972;51():11-42.
-
1972: Carlsson A; Lindqvist M
The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo.
Journal of neural transmission 1972;33(1):23-43.
-
1972: Kehr W; Carlsson A; Lindqvist M
A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.
Naunyn-Schmiedeberg's archives of pharmacology 1972;274(3):273-80.
-
1972: Carlsson A; Waldeck B
Formation of dopamine from 3-methoxytyrosine. Fact or artifact?
Naunyn-Schmiedeberg's archives of pharmacology 1972;272(4):441-6.
-
1972: Bergmark J; Carlsson A; Granerus A K; Jagenburg R; Magnusson T; Svanborg A
Decarboxylation of orally administered L-dopa in the human digestive tract.
Naunyn-Schmiedeberg's archives of pharmacology 1972;272(4):437-40.
-
1972: Bédard P; Carlsson A; Lindqvist M
Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1972;272(1):1-15.
-
1971: Meek J L; Fuxe K; Carlsson A
Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine.
Biochemical pharmacology 1971;20(3):707-9.
-
1971: Carlsson A
Basic concepts underlying recent developments in the field of Parkinson's disease.
Contemporary neurology series 1971;8():1-31.
-
1971: Bédard P; Carlsson A; Fuxe K; Lindqvist M
Origin of 5-hydroxytryptophan and l-dopa accumulating in brain following decarboxylase inhibition.
Naunyn-Schmiedebergs Archiv für Pharmakologie 1971;269(1):1-6.
-
1970: Carlsson A
Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices.
The Journal of pharmacy and pharmacology 1970;22(10):729-32.
-
1970: Carlsson A; Lindqvist M
Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition.
The Journal of pharmacy and pharmacology 1970;22(9):726-7.
-
1970: Carlsson A; Lindqvist M; Wysokowski J; Corrodi H; Junggren U
Substituted metatyramines as brain monoamine depletors.
Acta pharmaceutica Suecica 1970;7(3):293-302.
-
1970: Andén N E; Carlsson A; Kerstell J; Magnusson T; Olsson R; Roos B E; Steen B; Steg G; Svanborg A; Thieme G; Werdinius B
Oral L-dopa treatment of parkinsonism.
Acta medica Scandinavica 1970;187(4):247-55.
-
1969: Carlsson A; Jonason J; Lindqvist M
On the mechanism of 5-hydroxytryptamine release by thymoleptics.
The Journal of pharmacy and pharmacology 1969;21(11):769-73.
-
1969: Carlsson A; Lindqvist M
Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines.
The Journal of pharmacy and pharmacology 1969;21(7):460-4.
-
1969: Carlsson A; Fuxe K; Hamberger B; Malmfors T
Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.
British journal of pharmacology 1969;36(1):18-28.
-
1969: Carlsson A; Corrodi H; Fuxe K; Hökfelt T
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine.
European journal of pharmacology 1969;5(4):367-73.
-
1969: Carlsson A; Corrodi H; Fuxe K; Hökfelt T
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.
European journal of pharmacology 1969;5(4):357-66.
-
1969: Carlsson A; Jonason J; Lindqvist M; Fuxe K
Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine.
Brain research 1969;12(2):456-60.
-
1969: Carlsson A
Pseudo-transmitters.
Journal of neuro-visceral relations 1969;31():Suppl 9:249+.
-
1969: Carlsson A
Pharmacology of synaptic monoamine transmission.
Progress in brain research 1969;31():53-9.
-
1969: Andén N E; Carlsson A; Häggendal J
Adrenergic mechanisms.
Annual review of pharmacology 1969;9():119-34.
-
1968: Carlsson A; Meisch J J; Waldeck B
On the beta-hydroxylation of (+-)-alpha-methyldopamine in vivo.
European journal of pharmacology 1968;5(1):85-92.
-
1968: Carlsson A; Waldeck B
Different mechanisms of drug-induced release of noradrenaline and its congeners alpha-methylnoradrenaline and metaraminol.
European journal of pharmacology 1968;4(2):165-8.
-
1968: Carlsson A; Lindqvist M; Waldeck B
Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
European journal of pharmacology 1968;3(1):34-9.
-
1968: Carlsson A; Fuxe K; Ungerstedt U
The effect of imipramine on central 5-hydroxytryptamine neurons.
The Journal of pharmacy and pharmacology 1968;20(2):150-1.
-
1968: Carlsson A; Waldeck B
Release of alpha-methylated noradrenaline analogues by nialamide.
Acta pharmacologica et toxicologica 1968;26(6):501-6.
-
1967: Carlsson A; Fuxe K; Hökfelt T
Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
European journal of pharmacology 1967;2(3):196-201.
-
1967: Carlsson A; Lindqvist M
Metatyrosine as a tool for selective protection of catecholamine stores against reserpine.
European journal of pharmacology 1967;2(3):187-92.
-
1967: Carlsson A; Lundborg P; Stitzel R; Waldeck B
Uptake, storage and release of H3-alpha-methyl norepinephrine.
The Journal of pharmacology and experimental therapeutics 1967;158(2):175-82.
-
1967: Carlsson A
Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
The Journal of pharmacy and pharmacology 1967;19(11):783-4.
-
1967: Carlsson A
Neurohumoral transmission and neuropsychiatric disorders.
International journal of psychiatry 1967;4(3):218-9.
-
1967: Carlsson A; Fuxe K; Hökfelt T
Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate.
The Journal of pharmacy and pharmacology 1967;19(7):481-3.
-
1967: Carlsson A; Waldeck B
The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice.
The Journal of pharmacy and pharmacology 1967;19(3):182-90.
-
1967: Meisch J J; Carlsson A; Waldeck B
Effect of desipramine and reserpine on the in vivo beta-hydroxylation of alpha-methyl-m-tyramine and alpha-methyldopamine.
The Journal of pharmacy and pharmacology 1967;19(1):63-5.
-
1967: Carlsson A
Recent studies on the mode of action of antidepressive drugs.
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1967;257(1):115-7.
-
1966: Carlsson A; Fuxe K; Hamberger B; Lindqvist M
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
Acta physiologica Scandinavica 1966;67(3):481-97.
-
1966: Carlsson A; Waldeck B
Release of 3H-metaraminol by different mechanisms.
Acta physiologica Scandinavica 1966;67(3):471-80.
-
1966: Carlsson A; Waldeck B
Effects of amphetamine, tyramine, and protriptyline on reserpine-resistant amine-concentrating mechanisms of adrenergic nerves.
The Journal of pharmacy and pharmacology 1966;18(4):252-3.
-
1966: Carlsson A; Lindqvist M; Fuxe K; Hamberger B
The effect of (+)-amphetamine on various central and peripheral catecholamine-containing neurones.
The Journal of pharmacy and pharmacology 1966;18(2):128-30.
-
1966: Carlsson A; Lindqvist M; Fuxe K; Hökfelt T
Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines.
The Journal of pharmacy and pharmacology 1966;18(1):60-2.
-
1966: Carlsson A; Lindqvist M
The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine.
Acta pharmacologica et toxicologica 1966;24(2):112-20.
-
1966: Carlsson A; Waldeck B
Structure-activity relationships for release of 14C-octopamine from adrenergic nerves by phenylethylamines.
Acta pharmacologica et toxicologica 1966;24(2):255-62.
-
1965: Trcka V; Carlsson A
Mediodespidine, hypotensive reserpoid without sedative effect. II. Effect on monoamine levels in mouse organs.
Life sciences 1965;4(23):2263-7.
-
1965: CARLSSON A; THEORELL H
[THE ANDERS JAHRE MEDICAL PRIZE 1965.]
Nordisk medicin 1965;74():785-7.
-
1965: Carlsson A; Lindqvist M; Dahlström A; Fuxe K; Masuoka D
Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro.
The Journal of pharmacy and pharmacology 1965;17(8):521-3.
-
1965: Carlsson A
[The mechanism of action of neuroleptics and antidepressive drugs]
Läkartidningen 1965;62(25):1978-90.
-
1965: Carlsson A; Waldeck B
Rapid release of 3H-metaraminol induced by combined treatment with protriptyline and reserpine.
The Journal of pharmacy and pharmacology 1965;17(5):327-8.
-
1965: CARLSSON A; DAHLSTROEM A; FUXE K; LINDQVIST M
HISTOCHEMICAL AND BIOCHEMICAL DETECTION OF MONOAMINE RELEASE FROM BRAIN NEURONS.
Life sciences 1965;4():809-16.
-
1965: CARLSSON A; WALDECK B
INHIBITION OF 3H-METARAMINOL UPTAKE BY ANTIDEPRESSIVE AND RELATED AGENTS.
The Journal of pharmacy and pharmacology 1965;17():243-4.
-
1965: ANDEN N E; CARLSSON A; HILLARP N A; MAGNUSSON T
NORADRENALINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD.
Life sciences 1965;4():129-32.
-
1965: CARLSSON A; WALDECK B
MECHANISM OF AMINE TRANSPORT IN THE CELL MEMBRANES OF THE ADRENERGIC NERVES.
Acta pharmacologica et toxicologica 1965;22():293-300.
-
1965: CARLSSON A; DAHLSTROEM A; FUXE K; HILLARP N A
FAILURE OF RESERPINE TO DEPLETE NORADRENALINE NEURONS OF ALPHA-METHYLNORADRENALINE FORMED FROM ALPHA-METHYL DOPA.
Acta pharmacologica et toxicologica 1965;22():270-6.
-
1965: Utley J D; Carlsson A
Relative effects of L-DOPA and its methyl ester given orally or intraperitoneally to reserpine-treated mice.
Acta pharmacologica et toxicologica 1965;23(2):189-93.
-
1964: CARLSSON A; FOLKOW B; HAEGGENDAL J
SOME FACTORS INFLUENCING THE RELEASE OF NORADRENALINE INTO THE BLOOD FOLLOWING SYMPATHETIC STIMULATION.
Life sciences 1964;3():1335-41.
-
1964: CARLSSON A
EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONS.
Acta neurovegetativa 1964;26():484-93.
-
1964: ANDEN N E; CARLSSON A; DAHLSTROEM A; FUXE K; HILLARP N A; LARSSON K
DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.
Life sciences 1964;3():523-30.
-
1964: ANDEN N E; CARLSSON A; HILLARP N A; MAGNUSSON T
5-HYDROXYTRYPTAMINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD.
Life sciences 1964;3():473-8.
-
1964: SEIDEN L S; CARLSSON A
BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE.
Psychopharmacologia 1964;5():178-81.
-
1964: CARLSSON A; FALCK B; FUXE K; HILLARP N A
CELLULAR LOCALIZATION OF MONOAMINES IN THE SPINAL CORD.
Acta physiologica Scandinavica 1964;60():112-9.
-
1964: ANDEN N E; CARLSSON A; HILLARP N A
INHIBITION BY 5-HYDROXYTRYPTOPHAN OF INSULIN-INDUCED ADRENALINE DEPLETION.
Acta pharmacologica et toxicologica 1964;21():183-6.
-
1964: CARLSSON A; WALDECK B
A METHOD FOR THE FLUORIMETRIC DETERMINATION OF 3-METHOXYTYRAMINE IN TISSUES AND THE OCCURRENCE OF THIS AMINE IN BRAIN.
Scandinavian journal of clinical and laboratory investigation 1964;16():133-8.
-
1963: ANDEN N E; CARLSSON A; WALDECK B
RESERPINE-RESISTENT UPTAKE MECHANISMS OF NORADRENALINE IN TISSUES.
Life sciences 1963;12():889-94.
-
1963: CARLSSON A; JONASSON J; ROSENGREN E
TIME CORRELATION BETWEEN THE EFFECTS OF RESERPINE ON BEHAVIOUR AND STORAGE MECHANISM FOR ARYLALKYLAMINES.
Acta physiologica Scandinavica 1963;59():474-7.
-
1963: SEIDEN L S; CARLSSON A
TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE.
Psychopharmacologia 1963;4():418-23.
-
1963: CARLSSON A; MAGNUSSON T; ROSENGREN E
5-HYDROXYTRYPTAMINE OF THE SPINAL CORD NORMALLY AND AFTER TRANSECTION.
Experientia 1963;19():359.
-
1963: CARLSSON A; WALDECK B
BETA-HYDROXYLATION OF TYRAMINE IN VIVO.
Acta pharmacologica et toxicologica 1963;20():371-4.
-
1963: CARLSSON A; HILLARP N A; WALDECK B
ANALYSIS OF THE MG++-ATP DEPENDENT STORAGE MECHANISM IN THE AMINE GRANULES OF THE ADRENAL MEDULLA.
Acta physiologica Scandinavica. Supplementum 1963;():SUPPL215:1-38.
-
1963: CARLSSON A; LINDQVIST M
EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.
Acta pharmacologica et toxicologica 1963;20():140-4.
-
1963: CARLSSON A; WALDECK B
ON THE ROLE OF THE LIVER CATECHOL-O-METHYL TRANSFERASE IN THE METABOLISM OF CIRCULATING CATECHOLAMINES.
Acta pharmacologica et toxicologica 1963;20():47-55.
-
1962: CARLSSON A; HILLARP N A
Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine.
Acta physiologica Scandinavica 1962;55():95-100.
-
1962: CARLSSON A; FALCK B; HILLARP N A; TORP A
Histochemical localization at the cellular level of hypothalamic noradrenaline.
Acta physiologica Scandinavica 1962;54():385-6.
-
1962: CARLSSON A; LINDQVIST M
In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.
Acta physiologica Scandinavica 1962;54():87-94.
-
1962: CARLSSON A; LINDQVIST M
A method for the determination of normetanephrine in brain.
Acta physiologica Scandinavica 1962;54():83-6.
-
1962: CARLSSON A; FALCK B; HILLARP N A
Cellular localization of brain monoamines.
Acta physiologica Scandinavica. Supplementum 1962;56(196):1-28.
-
1962: CARLSSON A; HILLARP N A; WALDECK B
A Mg-ATP dependent storage mechanism in the amine granules of the adrenal medulla.
Medicina experimentalis. International journal of experimental medicine 1962;6():47-53.
-
1961: CARLSSON A; HILLARP N A
Uptake of phenyl and indole alkylamines by the storage granules of the adrenal medulla in vitro.
Medicina experimentalis. International journal of experimental medicine 1961;5():122-4.
-
1961: CARLSSON A; FALCK B; HILLARP N A; THIEME G; TORP A
A new histochemical method for visualization of tissue catechol amines.
Medicina experimentalis. International journal of experimental medicine 1961;4():123-5.
-
1959: CARLSSON A; RASMUSSEN E B; KRIST JANSEN P
The urinary excretion of adrenaline and noradrenaline by schizophrenic patients during reserpine treatment.
Journal of neurochemistry 1959;4():318-20.
-
1959: CARLSSON A; RASMUSSEN E B; KRISTJANSEN P
The urinary excretion of adrenaline and noradrenaline by depressive patients during iproniazid treatment.
Journal of neurochemistry 1959;4():321-4.
-
1959: CARLSSON A
The occurrence, distribution and physiological role of catecholamines in the nervous system.
Pharmacological reviews 1959;11(2, Part 2):490-3.
-
1959: CARLSSON A
Detection and assay of dopamine.
Pharmacological reviews 1959;11(2, Part 2):300-4.
-
1959: BERTLER A; CARLSSON A; ROSENGREN E
Fluorimetric method for differential estimation of the 3-O-methylated derivatives of adrenaline and noradrenaline (metanephrine and normetanephrine.
Clinica chimica acta; international journal of clinical chemistry 1959;4(3):456-7.
-
1958: CARLSSON A; WALDECK B
A fluorimetric method for the determination of dopamine (3-hydroxytyramine).
Acta physiologica Scandinavica 1958;44(3-4):293-8.
-
1958: BERTLER A; CARLSSON A; ROSENGREN E
A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.
Acta physiologica Scandinavica 1958;44(3-4):273-92.
-
1958: CARLSSON A; HILLARP N A
On the state of the catechol amines of the adrenal medullary granules.
Acta physiologica Scandinavica 1958;44(2):163-9.
-
1958: BERTLER A; CARLSSON A; LINDQVIST M; MAGNUSSON T
On the catehol amine in blood plasma after stimulation of the sympathoadrenal system.
Experientia 1958;14(5):184-5.
-
1958: CARLSSON A; LINDQVIST M; MAGNUSSON T; WALDECK B
On the presence of 3-hydroxytyramine in brain.
Science (New York, N.Y.) 1958;127(3296):471.
-
1957: CARLSSON A; LINDQVIST M; MAGNUSSON T
3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.
Nature 1957;180(4596):1200.
-
1957: CARLSSON A; SHORE P A; BRODIE B B
Release of serotonin from blood platelets by reserpine in vitro.
The Journal of pharmacology and experimental therapeutics 1957;120(3):334-9.
-
1957: CARLSSON A; HILLARP N A; HOKFELT B
The concomitant release of adenosine triphosphate and catechol amines from the adrenal medulla.
The Journal of biological chemistry 1957;227(1):243-52.
-
1957: SHORE P A; PLETSCHER A; TOMICH E G; CARLSSON A; KUNTZMAN R; BRODIE B B
Role of brain serotonin in reserpine action.
Annals of the New York Academy of Sciences 1957;66(3):609-15; discussion, 615-7.
-
1956: CARLSSON A; HILLARP N A
Release of adenosine triphosphate along with adrenaline and noradrenaline following stimulation of the adrenal medulla.
Acta physiologica Scandinavica 1956;37(2-3):235-9.
-
1955: CARLSSON A; MAGNUSSON T
Failure to demonstrate antipyretic and analgesic properties of salicylamides.
Acta pharmacologica et toxicologica 1955;11(3):248-53.
Sign-in to see more